The Five-Day Cream for Actinic Keratosis

What is tirbanibulin and how does it work?

Tirbanibulin is a topical medication approved for actinic keratosis, sold under the brand name Klisyri. It belongs to a class of drugs that disrupts microtubules, the internal scaffolding cells use to divide, which selectively stresses the abnormal, rapidly turning-over cells in a sun-damaged patch of skin more than the normal skin around them. It is applied to a defined area of the face or scalp once a day for five consecutive days and then stopped entirely — there is no maintenance phase and no repeat application unless a clinician reassesses the area later and decides another course is warranted.

Lesion-directed versus field therapy — where does tirbanibulin fit?

Actinic keratosis treatment generally splits into two approaches: lesion-directed therapy, most often cryotherapy with liquid nitrogen aimed at one spot at a time, and field therapy, applied across a wider area to treat visible spots along with the invisible, early sun damage surrounding them 1Ref 1American Family Physician (2007).Treatment Options for Actinic Keratoses.Supports the general lesion-directed (cryotherapy) versus field-therapy (5-fluorouracil, imiquimod, diclofenac, photodynamic therapy) framing used to place tirbanibulin among established actinic keratosis options.. Topical 5-fluorouracil, imiquimod, and photodynamic therapy are the other established options in the field-therapy family, and each treats the same underlying idea — that a patch of chronically sun-exposed skin usually holds more damage than the handful of rough spots a person can feel or see 1Ref 1American Family Physician (2007).Treatment Options for Actinic Keratoses.Supports the general lesion-directed (cryotherapy) versus field-therapy (5-fluorouracil, imiquimod, diclofenac, photodynamic therapy) framing used to place tirbanibulin among established actinic keratosis options..

An actinic keratosis field therapy comparison across these options mostly comes down to trade-offs in course length, the intensity of the skin reaction, and how many clinic visits are involved; tirbanibulin's main distinction within that group is that its course is measured in days rather than weeks. Older field therapies such as 5-fu for actinic keratosis or imiquimod for AK typically run several weeks, and photodynamic therapy involves an in-office light treatment rather than a take-home cream — different logistics, aimed at the same field-wide goal.

What does the five-day course actually look like?

The medication is applied once daily to the treatment area for five straight days. Redness, flaking, and mild swelling typically begin within the first few days and tend to peak in the days just after the course ends, then settle over the following one to two weeks. This reaction is expected and is generally a sign the medication is reaching abnormal cells across the field, not a sign that something has gone wrong. The treated skin is usually left uncovered rather than bandaged, and many people find the reaction is milder and shorter-lived than what they experienced with a multi-week field therapy in the past, though reactions vary by person and by how much sun damage the area actually carries.

Who tends to be a good candidate?

Tirbanibulin is generally used on the face or scalp, areas where a shorter, more cosmetically tolerable course matters most because the skin is visible and thinner than on the trunk or limbs. It suits people with a defined patch of multiple actinic keratoses rather than a single isolated spot, since a lesion-directed option like cryotherapy is often simpler and just as effective for one spot alone. People who have not tolerated the longer reaction from an older field therapy, or who need a course that fits into a shorter window before travel or an event, often ask about it specifically for that reason.

Not every actinic keratosis needs treatment right away, and the broader question of treating actinic keratosis in general, versus simply watching a faint spot, is a separate decision a clinician weighs before recommending any field therapy at all. As with any field therapy, tirbanibulin does not treat the reservoir of sun damage permanently — new actinic keratoses can still develop elsewhere on chronically sun-exposed skin over time, which is why ongoing skin checks matter regardless of which treatment is used.

What tirbanibulin is not for

Tirbanibulin treats actinic keratosis, a precancerous change, not skin cancer itself. A spot that is thickening rapidly, becoming tender, ulcerating, bleeding without an obvious cause, or changing in shape or color is behaving differently from a typical actinic keratosis, and that difference is the point.

Those are features that call for a biopsy rather than a field-therapy cream, because they can signal a squamous cell carcinoma that has already developed, or an entirely different process like melanoma, which is diagnosed and staged differently and is treated with excision, sentinel lymph node evaluation, and sometimes immunotherapy or targeted therapy rather than a topical field agent 2Ref 2National Cancer Institute (PDQ Adult Treatment Editorial Board) (2025).Melanoma Treatment (PDQ®)–Health Professional Version.Supports the differential point that a changing or atypical lesion may be melanoma, which is diagnosed and treated (excision, sentinel node evaluation, immunotherapy or targeted therapy) very differently from actinic keratosis field therapy.. A description alone, even a careful one, cannot substitute for a clinician looking at and often biopsying a lesion that stands out from the rest of the field.

What happens after the reaction settles?

Once the redness and flaking resolve, the treated skin is reassessed, usually around a couple of months out, to see how much of the field has cleared. Some actinic keratoses resolve completely; others may persist or recur, in which case a clinician decides whether to repeat the same field therapy, switch approaches, or treat any remaining individual spots with cryotherapy. Because actinic keratosis reflects cumulative sun exposure rather than a one-time event, ongoing sun protection and periodic skin exams remain part of the plan regardless of how well a single course works.